Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • CDSCO adds another...

    CDSCO adds another port for enhancing import of drugs

    Farhat NasimWritten by Farhat Nasim Published On 2019-10-13T15:37:51+05:30  |  Updated On 13 Oct 2019 3:37 PM IST
    CDSCO adds another port for enhancing import of drugs

    New Delhi: Through a recent Gazette notification, the apex drug regulatory body Central Drugs Standard Control Organization (CDSCO) has apprised about the addition of one more port namely, Inland Container Depot Dhannad, Indore in Madhya Pradesh in order enhance the import of drugs into India.


    ICD Dhannad is the first private port of Central India.

    In this regard, the Government has made necessary amendments in the Drugs and Cosmetics Rules, 1945. In exercise of the powers conferred under sections 12 and 33 of the Drugs and Cosmetics Act, 1940 (23 of 1940), the Central Government, after consultation with the Drugs Technical Advisory Board, hereby makes the following rules further to amend the Drugs and Cosmetics Rules, 1945, namely:-




    In the Drugs and Cosmetics Rules, 1945, in rule 43A, after the words “Mundra Port in Gujarat”, the words “and Inland Container Depot Dhannad, Indore in Madhya Pradesh” shall be inserted.



    Also Read: CDSCO Committee to draft new guidelines for effective recall of substandard drugs

    Rule 43A of the Drugs and Cosmetics Rules, 1945 reads;

    No drug shall be imported into India except through one of the following places, namely: -




    • Ferozepur Cantonment and Amritsar RailwayStations: in respect of drugs imported by rail across the frontier with Pakistan.

    • Ranaghat, Bongaon and Mohiassan Railway Stations: In respect of drugs imported by rail across the frontier with Bangladesh.

    • Petrapole Road in West Bengal, Sutarkandi in Assam, Old Raghna Bazar and Agartala in Tripura: in respect of drugs imported by Road from Bangladesh.

    • Raxual: In respect of drugs imported by road and railway lines connecting Raxual in India and Birganj in Nepal.

    • Chennai, Kolkatta, Mumbai, Cochin, Nhava Sheva, Kandla and Inland Container Depots at Tuglakabad and Patparganj in Delhi and Tuticorin in Tamil Nadu and Marmugao port in Goa: in respect of drugs imported by sea into India.

    • Chennai, Kolkata, Mumbai, Delhi, Ahmedabad, Hyderabad, Goa and Bengaluru: in respect of drugs imported by air into India



    However, with the latest amendment, one more port for the import of drugs in the country has been added to the list now. Prior to the amendment, the Government had invited suggestions from stakeholder via a draft published on 12th March 2019. However, no objections or suggestions were received from the stakeholders and the amendment came into effect from September 13, 2019.


    Also Read: Health Ministry reprimands CDSCO officers for frequent visit to ministry office
    CDSCOCentral Drugs Standard Control OrganizationdrugsDrugs and Cosmetics ActDrugs and Cosmetics Rules 1945Drugs Technical Advisory BoardDTABimport of drugsIndoreinland container depot dhannadMadhya Pradesh

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok